IRO is advancing programs across the full ecosystem of CGT organizations, each with different constraints, workflows, and scale requirements:
Trusted by Teams Advancing the Next Generation of CGT.
From global pharma to emerging biotech, teams are already seeing measurable impact with IRO® across biology, process control, and operational efficiency.
Adopted Across the CGT Landscape.
Global pharmaceutical companies
Advancing late-stage programs toward commercial readiness and supporting commercial programs toward expanded commercial success
Small and mid-sized biotech teams
Accelerating early development with better process control, reduced vector usage, and clearer paths to scale
Academic Medical Centers (AMCs)
Moving from research to clinic with reproducible processes and scalable manufacturing workflows
CDMOs
Scaling across multiple client programs while improving process consistency, throughput, and cost efficiency
Across the various stages of development, IRO is delivering one consistent outcome: better control, better biology, and faster progress.
IRO customers report meaningful results.
Across key development and manufacturing metrics, with benefits emerging quickly after implementation.
Better Biology
Consistent, Measurable Biological Improvement
Customers consistently report improved transduction efficiency, higher yields, and more reproducible outcomes, driven by precise process control.
Ease of Use
Designed to Work the Way Teams Actually Work
IRO fits into existing workflows fast. Customers find it intuitive from day one, with the flexibility and control to keep optimizing as their process evolves.
Technical Guidance
A True Partner In Process Development
Beyond the platform itself, Ori offers the depth of support from onboarding through continued optimization using IRO.
